F Bianchi, S Pretto, E Tagliabue, A Balsari… - Cancer biology & …, 2017 - Taylor & Francis
ABSTRACT TLR3 belong to the Toll-like receptors family, it is mainly expressed on immune cells where it senses pathogen-associated molecular patterns and initiates innate immune …
H Li, Y Xiao, Q Li, J Yao, X Yuan, Y Zhang, X Yin… - Cancer cell, 2022 - cell.com
Reinvigoration of antitumor immunity remains an unmet challenge. Our retrospective analyses revealed that cancer patients who took antihistamines during immunotherapy …
NA Massari, MB Nicoud… - British journal of …, 2020 - Wiley Online Library
In the present review, we will discuss the recent advances in the understanding of the role of histamine and histamine receptors in cancer biology. The controversial role of the …
High levels of histamine and histamine receptors (HRs), including H1R~ H4R, are found in many different types of tumor cells and cells in the tumor microenvironment, suggesting their …
I Fritz, P Wagner, H Olsson - Translational oncology, 2021 - Elsevier
Background We have previously shown an association with substantially improved survival in breast cancer and melanoma for desloratadine and loratadine users, and set out to find …
Preclinical, clinical, and epidemiological studies indicate that vitamin D3 (VD) deficiency is a risk factor for the development of breast cancer. Underlying mechanisms include the ability …
Cancer is the second leading cause of death globally and its incidence and mortality are rapidly increasing worldwide. The dynamic interaction of immune cells and tumor cells …
M Varalda, A Antona, V Bettio, K Roy… - Frontiers in …, 2020 - frontiersin.org
Background and Purpose: Drug repositioning is a promising strategy for discovering new therapeutic strategies for cancer therapy. We investigated psychotropic drugs for their …